Clinical Trials Directory

Trials / Completed

CompletedNCT01869062

Clinical Assessment of the SonR Algorithm in the PARADYM RF SonR CRT-D by Echocardiography

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
348 (actual)
Sponsor
MicroPort CRM · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The main objective of the SONR-ECHO trial is to demonstrate that optimization of CRT parameters by SonR technology is able to increase the rate of CRT-D responders, based on significant LV reverse remodeling, as compared to Standard of Care settings. This study will also evaluate the effectiveness of CRT-D SonR system as compared to Standard of care (SoC) programming methods in providing appropriate LV filling, as expected from the Ritter method.

Detailed description

This study will evaluate the effectiveness of CRT-D SonR system as compared to SoC programming methods to: * Increase the rate of patients responding to CRT * Provide appropriate hemodynamic cardiac effect, as expected from the Ritter method. The identification of CRT responders, as defined by echocardiography, generally refers to a significant reduction of the LV End-Systolic Diameter (LVESD) and/or LVESV during Follow-Up (FUp). Patients will be considered as responders to CRT if their LVESV decreased by \> 15% after 6 months of CRT therapy as compared to baseline. The percentage of CRT responders will be compared between the two study arms. SoC is defined as the standard CRT system programming/optimization method currently used by physicians in study centers and any method may be used in the study if considered as routine practice in the study center.

Conditions

Interventions

TypeNameDescription
DEVICESonR CRT Optimization 'On'Intervention: Implanted CRT-D device with the SonR optimization algorithm programmed being 'on'.
DEVICESonR CRT Optimization 'Off'Intervention: Implanted CRT-D device with the SonR optimization algorithm programmed being 'off' (Standard of Care).

Timeline

Start date
2013-06-01
Primary completion
2016-05-19
Completion
2016-05-19
First posted
2013-06-05
Last updated
2019-03-22

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01869062. Inclusion in this directory is not an endorsement.